In connection with its planned separation into two independent, publicly traded companies, Brooks Automation, Inc. (the 'Company') previously announced that David E. Jarzynka will be named Chief Executive Officer of the new semiconductor automation company upon the separation. On August 19, 2021, Mr. Jarzynka informed the Company that for personal reasons he has decided to withdraw as incoming Chief Executive Officer of the new semiconductor automation company. Mr. Jarzynka remains in his current role with the Company as the President of the Semiconductor Solutions Group business.
Attachments
Original document
Permalink
Disclaimer
Brooks Automation Inc. published this content on 23 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 August 2021 13:03:04 UTC.
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Companyâs segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
AZENTA, INC. 
